Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAlcohol is not banned while you're taking weight loss injections like Mounjaro or Wegovy, but there are real reasons to think carefully about how much you drink. These medicines slow gastric emptying, alter appetite signals and can intensify alcohol's effects, so the same number of drinks may hit harder than it used to. They're prescription-only medicines, assessed individually by a clinician before use. How alcohol fits into your treatment is worth discussing at that consultation — and this page covers what the clinical evidence currently says.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There is no hard pharmacological prohibition in the prescribing information for tirzepatide or semaglutide that says alcohol is completely off-limits. What the NHS medicines guidance for tirzepatide does note is that you should limit alcohol, because drinking can make side effects (particularly nausea and dizziness) worse.
The mechanism matters here. Both medicines slow gastric emptying, meaning food and drink linger in the stomach longer than usual. For alcohol, that can produce a lag followed by a sharper peak: you may feel fine for longer, then feel noticeably more affected than the number of drinks would normally warrant. This catches some people off guard, especially in the first few months of treatment. A question our prescribers hear regularly is whether the medicine itself changed their tolerance — and the honest answer is that it may well have.
Low blood sugar (hypoglycaemia) is not typically a risk with these medicines when used for weight management in people without diabetes, but if you are also managing type 2 diabetes with other medication, alcohol's effect on blood glucose adds another layer worth discussing with your prescriber. Pancreatitis is a known, infrequent but serious risk with GLP-1 medicines; heavy drinking is independently a risk factor for pancreatitis, so combining the two is something your clinical team will want to know about. If you develop severe stomach pain that radiates to the back, seek urgent medical attention.
Weight loss injections work partly by reducing appetite and increasing the sense of fullness after eating. Alcohol does not work through those same signals. A glass of wine or a couple of pints carries meaningful calories (typically 150–200 kcal each) without generating the hormonal feedback that triggers satiety on GLP-1 treatment. In practice, that means alcohol calories accumulate without the usual brake.
There is also an indirect effect. Alcohol tends to lower inhibitions around food choices, and the late-night snack after a few drinks is a pattern that persists even when appetite is otherwise reduced on treatment. If you are finding your progress has stalled despite being on treatment, alcohol intake is one of the first lifestyle factors worth reviewing honestly.
None of this means a glass of something on a Friday evening will undo months of progress. It means regular, heavy drinking is genuinely at odds with what these medicines are trying to do, and that even moderate drinking deserves a place in the conversation with your prescriber, particularly if results are not tracking as expected. Understanding the cost of treatment is one thing; getting the most from it is another.
The NHS recommends limiting alcohol generally, and that guidance applies with additional weight here. A few specific points are worth keeping in mind.
Drink with food rather than on an empty stomach, and keep the amounts modest. The slowed emptying effect means you cannot always predict how quickly alcohol will affect you, so drinking less than you might normally is a sensible precaution, particularly in the early weeks of starting injections or after a dose change, when nausea is more likely anyway.
Hydration matters more than usual on GLP-1 treatment. Alcohol is a diuretic, and if you are already managing nausea or reduced appetite, adding dehydration into the mix can make side effects feel worse. Spacing drinks with water is practical, not just a pub cliché. Holidays are worth mentioning here: the combination of heat, more alcohol than usual and an unfamiliar routine can make side effects flare up at exactly the time you'd rather not be dealing with them, worth planning for rather than being surprised by.
If you are unsure how alcohol fits into your specific situation (because of other medicines, a health condition, or just because your tolerance seems to have changed) our FAQs cover some of the common questions, and your prescriber is the right person to ask directly. You can also read about specific questions around drinking on these medicines or what the clinical guidance actually says about drinking during treatment.
If you are considering starting treatment and want a prescriber to review your full picture (including your alcohol intake) you can start a free consultation with our clinical team at any point. The review is done the same day by a real prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.